Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Follicular × Selenium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Rituximab 113 Cyclophosphamide 102 Peripheral Blood Stem Cell Transplantation 47 fludarabine phosphate 45 Etoposide 42 Radiotherapy 38 Mycophenolic Acid 37 Filgrastim 37 Whole-Body Irradiation 32 Tacrolimus 32 Busulfan 28 Melphalan 27 Cytarabine 26 Cyclosporine 26 Vincristine 25 Methotrexate 25 Prednisone 24 Antilymphocyte Serum 23 sargramostim 22 Doxorubicin 21 Lenalidomide 20 obinutuzumab 18 Carmustine 18 Bendamustine Hydrochloride 17 fludarabine 16 Methylprednisolone 16 Dexamethasone 16 Bortezomib 16 ibritumomab tiuxetan 13 Cisplatin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡